错误部

The Lancet Pub Date : 2025-06-19 DOI:10.1016/s0140-6736(25)01251-6

{"title":"错误部","authors":"","doi":"10.1016/s0140-6736(25)01251-6","DOIUrl":null,"url":null,"abstract":"Terkelsen CJ, Freeman P, Dahl JS, et al. SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial. Lancet 2025; 405: 1362–72—In this Article, the last sentence in the Results section should read “At 1 year, patients treated with SAPIEN 3 THVs walked a median of 382 m (IQR 295–450) on the 6-min walk test, whereas patients treated with Myval THVs walked 383 m (300–450; p=0·43).” These corrections have been made to the online version as of June 19, 2025.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Department of Error\",\"authors\":\"\",\"doi\":\"10.1016/s0140-6736(25)01251-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Terkelsen CJ, Freeman P, Dahl JS, et al. SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial. Lancet 2025; 405: 1362–72—In this Article, the last sentence in the Results section should read “At 1 year, patients treated with SAPIEN 3 THVs walked a median of 382 m (IQR 295–450) on the 6-min walk test, whereas patients treated with Myval THVs walked 383 m (300–450; p=0·43).” These corrections have been made to the online version as of June 19, 2025.\",\"PeriodicalId\":22898,\"journal\":{\"name\":\"The Lancet\",\"volume\":\"26 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0140-6736(25)01251-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0140-6736(25)01251-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

Terkelsen CJ, Freeman P， Dahl JS等。SAPIEN 3与Myval经导管心脏瓣膜经导管主动脉瓣植入术（COMPARE-TAVI 1）：一项多中心、随机、非劣效性试验。《柳叶刀》2025年;405: 1362 - 72 -在这篇文章中，结果部分的最后一句话应该是“在1年，接受SAPIEN 3 thv治疗的患者在6分钟步行测试中步行的中位数为382米（IQR 295-450），而接受Myval thv治疗的患者步行的中位数为383米(300-450；p = 0·43)。”这些更正已于2025年6月19日对在线版本进行了修改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Department of Error

Terkelsen CJ, Freeman P, Dahl JS, et al. SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial. Lancet 2025; 405: 1362–72—In this Article, the last sentence in the Results section should read “At 1 year, patients treated with SAPIEN 3 THVs walked a median of 382 m (IQR 295–450) on the 6-min walk test, whereas patients treated with Myval THVs walked 383 m (300–450; p=0·43).” These corrections have been made to the online version as of June 19, 2025.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Lancet

自引率

0.00%

发文量